{"id":"https://openalex.org/W4361919682","doi":"https://doi.org/10.1158/1078-0432.22460531.v1","title":"Supplementary Figures Legends from Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy","display_name":"Supplementary Figures Legends from Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361919682","doi":"https://doi.org/10.1158/1078-0432.22460531.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22460531.v1","doi":"https://doi.org/10.1158/1078-0432.22460531.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460531.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22460531.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007502207","display_name":"Martin Skarzynski","orcid":"https://orcid.org/0000-0003-0274-0160","observed_orcids":["https://orcid.org/0000-0003-0274-0160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Skarzynski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057884204","display_name":"Carsten Utoft Niemann","orcid":"https://orcid.org/0000-0001-9880-5242","observed_orcids":["https://orcid.org/0000-0001-9880-5242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carsten U. Niemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036527685","display_name":"Yuh Shan Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuh Shan Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063267719","display_name":"Sabrina E. Martyr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabrina Martyr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108491565","display_name":"Irina Mari\u0107","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irina Maric","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008205966","display_name":"Dalia Salem","orcid":"https://orcid.org/0000-0002-4209-2260","observed_orcids":["https://orcid.org/0000-0002-4209-2260"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalia Salem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065696086","display_name":"Maryalice Stetler\u2010Stevenson","orcid":"https://orcid.org/0000-0003-2591-0353","observed_orcids":["https://orcid.org/0000-0003-2591-0353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maryalice Stetler-Stevenson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113663500","display_name":"Gerald E. Marti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald E. Marti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044681793","display_name":"Katherine R. Calvo","orcid":"https://orcid.org/0000-0002-0771-4191","observed_orcids":["https://orcid.org/0000-0002-0771-4191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine R. Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014636271","display_name":"Constance M. Yuan","orcid":"https://orcid.org/0000-0002-2601-3665","observed_orcids":["https://orcid.org/0000-0002-2601-3665"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Constance Yuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078585973","display_name":"Janet Valdez","orcid":"https://orcid.org/0000-0003-1913-4781","observed_orcids":["https://orcid.org/0000-0003-1913-4781"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet Valdez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050525368","display_name":"Susan Soto","orcid":"https://orcid.org/0009-0003-3746-890X","observed_orcids":["https://orcid.org/0009-0003-3746-890X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Soto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019310230","display_name":"Mohammed Z.H. Farooqui","orcid":"https://orcid.org/0009-0009-0248-3476","observed_orcids":["https://orcid.org/0009-0009-0248-3476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Z.H. Farooqui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066494072","display_name":"Sarah E. M. Herman","orcid":"https://orcid.org/0000-0002-3044-9840","observed_orcids":["https://orcid.org/0000-0002-3044-9840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah E.M. Herman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030524385","display_name":"Adrian U. Wiestner","orcid":"https://orcid.org/0000-0002-3533-2924","observed_orcids":["https://orcid.org/0000-0002-3533-2924"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian Wiestner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.859000027179718},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.7179999947547913},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8190000057220459},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.951802134513855},{"id":"https://openalex.org/C148220186","wikidata":"https://www.wikidata.org/wiki/Q7111912","display_name":"Outcome (game theory)","level":2,"score":0.647607147693634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3879658877849579},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.32766497135162354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.206864595413208},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.17038759589195251},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.08594149351119995},{"id":"https://openalex.org/C144237770","wikidata":"https://www.wikidata.org/wiki/Q747534","display_name":"Mathematical economics","level":1,"score":0.0686943531036377},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22460531.v1","doi":"https://doi.org/10.1158/1078-0432.22460531.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460531.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22460531","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_Legends_from_Interactions_between_Ibrutinib_and_Anti-CD20_Antibodies_Competing_Effects_on_the_Outcome_of_Combination_Therapy/22460531","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22460531.v1","doi":"https://doi.org/10.1158/1078-0432.22460531.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460531.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1712566393","https://openalex.org/W4361952369","https://openalex.org/W2133877408","https://openalex.org/W2018571395","https://openalex.org/W2975205060","https://openalex.org/W2552325609","https://openalex.org/W2338207523","https://openalex.org/W6977412605","https://openalex.org/W7207917609","https://openalex.org/W2528120132"],"abstract_inverted_index":{"Supplementary":[0],"Figures":[1],"Legends":[2],"from":[3],"Interactions":[4],"between":[5],"Ibrutinib":[6],"and":[7],"Anti-CD20":[8],"Antibodies:":[9],"Competing":[10],"Effects":[11],"on":[12],"the":[13],"Outcome":[14],"of":[15],"Combination":[16],"Therapy":[17]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}